Skip to the page

Data / Form D filings / Drug Hunter, Inc.

Drug Hunter, Inc.: Form D filings

Drug Hunter, Inc., a company in Portland, OR, filed 4 Form D notices with the SEC between 2022 and 2025. The latest, on September 19, 2025, reports $6 million sold of a $7 million offering to 13 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
111 SW 5th Ave, #3150, Portland, OR, 97204
Phone
(650) 458-7087
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1904600

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 19, 2025New notice$7,043,380$6,043,381$999,99913Sep 5, 2025sec.gov
Mar 15, 2024New notice$2,000,000$50,000$1,950,0001Mar 15, 2024sec.gov
Jan 9, 2023Amendment$1,500,000$698,382$801,6189Jan 7, 2022sec.gov
Jan 13, 2022New notice$1,500,000$198,381$1,301,6192Jan 7, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Dennis X. HuExecutive Officer, Director, Promoter
Thomas X. LehrmanDirector

Other companies in Oregon that filed recently

Every Form D from the week of Sep 15, 2025 · All recent filings in Oregon · All recent Other filings

Read from SEC EDGAR. Amount sold is what Drug Hunter, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.